As ageing compound management systems need to be renewed or replaced and market practices advance, companies are faced with different options from outsourcing to investing in new technologies in order to maintain momentum.
However, the balance between the mounting pressure to control costs in drug discovery with maintaining production rates, efficiently coordinating comprehensive libraries and working out how best to store them: remains a complex task for the industry.
This task leaves pharma firms with the challenge of not only achieving effective next generation innovation within compound management but also to innovate smartly in an economic sense.
Pharma IQ spoke to a selection of industry heavyweights on this matter to gain their insight.
Download PDF Attachment